ArticleJournal of racial and ethnic health disparities2017
Exploring Willingness to Participate in Clinical Trials by Ethnicity.
Article in Journal of racial and ethnic health disparities, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 50 citations in OpenAlex.
- Prospective preference assessment for the Ecstasy for Alleviating Severe Chronic Neuropathic Pain (EASE-Pain) trial.Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2025Trial
- Article
- Interest in and Predictors of Engagement With a Virtual Reality Intervention Among People With Chronic Pain: Cross-Sectional Survey Study.JMIR human factors · 2026Article
- Reporting and representation of participant race and ethnicity in phase III clinical trials for solid tumors.Future science OA · 2025Article
- Reporting and representation of race and ethnicity data in phase III clinical trials for hematological malignancies.Future science OA · 2025Article
- Effect of HLA restriction on racial and ethnic disparities in access to immune therapies for advanced synovial sarcoma.The oncologist · 2025Article
- Age, race and ethnicity, and sex of participants in clinical trials related to obesity.Obesity (Silver Spring, Md.) · 2025Article
- Measuring Representativeness in Clinical Trials.Circulation · 2025Review
- Promoting Racial Justice in Cancer Clinical Trials: Community Engaged Solutions for Bridging Gaps.Cancer medicine · 2025Article
- Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center.Frontiers in oncology · 2025Article
- COVID-19 clinical trial participation and awareness in Texas.Human vaccines & immunotherapeutics · 2024Article
- Investigating racial and gender disparities in virtual randomized clinical trial enrollment: Insights from the BE ACTIVE study.American heart journal · 2024Article
- Influences on clinical trial participation: Enhancing recruitment through a gender lens - A scoping review.Contemporary clinical trials communications · 2024Article
- Effects of historical inequity and institutional power on cannabis research: Moving toward equity and inclusion.PNAS nexus · 2023Article
- Involvement of Diverse Populations in Transfusion Medicine Research.Transfusion medicine reviews · 2023Article
- Research recruitment and consent methods in a pandemic: a qualitative study of COVID-19 patients' perspectives.BMC medical research methodology · 2023Article
- Reimagining diversity in multiple myeloma clinical trials.Hematological oncology · 2022Article
- Disparities in awareness of and willingness to participate in cancer clinical trials between African American and White cancer survivors.BMC cancer · 2022Article
- Willingness to Participate in Health Research: Mexican and Mexican American Women's Perspectives.Women's health reports (New Rochelle, N.Y.) · 2022Article
- Prostate cancer patients' self-reported participation in research: an examination of racial/ethnic disparities.Cancer causes & control : CCC · 2021Article
Corrections and comments
- Erratum issued
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
African-Americans and Hispanic-Americans are disproportionately affected by cancer, yet underrepresented in cancer clinical trials. Because of this, it is important to understand how attitudes and beliefs about clinical trials vary by ethnicity. A national, random sample of 860 adults was given an online survey about attitudes toward clinical trials. We examined willingness to participate in clinical trials, attitudes toward clinical trials, trust in doctors, attitudes toward alternative and complementary medicine, and preferred information channels. Results indicate that African-American and Hispanic-American participants have more negative attitudes about clinical trials, more distrust toward doctors, more interest in complementary and alternative medicine, and less willingness to participate in clinical trials than white/non-Hispanics, although specific factors affecting willingness to participate vary. The channels people turn to for information on clinical trials also varied by ethnicity. These results help explain the ethnic disparities in cancer clinical trial enrollment by highlighting some potential underlying causes and drawing attention to areas of importance to these groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.